HOME >> BIOLOGY >> NEWS
Colon Cancer Alliance launches interactive support program

CHICAGO September 14, 2006 -- Every four minutes someone in the United States is diagnosed with colorectal cancer, a diagnosis that can be overwhelming without appropriate information and support. People living with colorectal cancer now have the opportunity to exchange ideas and information with experts in the field and fellow patients through an educational workshop series called "Conversations About Colorectal Cancer." The program launches this weekend at the Colon Cancer Alliance's (CCA) 6th Annual Colorectal Cancer Conference in Chicago.

The two-day interactive conference will allow patients to have a dialogue with thought-leading physicians in the area of colorectal cancer on a range of topics, from the latest treatment advances with targeted therapies to managing their side effects. In addition, patients and caregivers will have the opportunity to listen to, and support one another, in their collective battle against colorectal cancer.

"This program is an important way for those living with colorectal cancer to learn more about the nation's second-leading cancer killer," says Amy Kelly, Co-Founder and Executive Director of the Colon Cancer Alliance. "By encouraging increased dialogue between patients, health care providers and caregivers, we hope to help patients learn how to successfully continue their daily activities and ultimately improve their quality of life."

According to a Harris Interactive survey of more than 500 cancer patients and 300 oncologists, patients who held discussions with their physicians about cancer topics were more knowledgeable about their condition than those who did not hold discussions. For example, only 10 percent of patients who did not participate in dialogue with their physician were knowledgeable about the extent of available treatment options. In addition, patients who did not have discussions with their physician were less knowledgeable about the possibility of treatment delays, infe
'"/>

Contact: Amy E. Kelly
akelly@ccalliance.org
954-341-0212
Porter Novelli
14-Sep-2006


Page: 1 2

Related biology news :

1. Smithsonian Fragmentation Project threatened by Amazon Colonization Plan
2. Kidnapped: Colon cancer seizes hapless nerve growth protein
3. Journalists can register now for ECCO 14 -- the European Cancer Conference
4. Cancer cures could work for canines and humans
5. The Cancer Genome Atlas awards funds for technology development
6. Cancer research specialist and HSPH professor awarded Medal of Honor from WHO cancer agency
7. Cancer stem cells similar to normal stem cells can thwart anti-cancer agents
8. Cancer stem cells can go it alone
9. Cancer drug enhances long-term memory
10. Cancer cells reprogram energy needs to grow and spread, study suggests
11. Cancer scientists create human leukemia process to map how disease begins, progresses

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Colon Cancer Alliance launches interactive support program

(Date:7/21/2015)... YORK , July 21, 2015 ... systems, as seen in the recent U.S. Office ... a solution to the infosec conundrum, but developers ... is stored. To address this dilemma, Biometrics-as-a-Service provider ... its Biometric Tokenization SDK for third party integration. ...
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
(Date:7/8/2015)... SAN DIEGO , July 8, 2015 /PRNewswire/ ... of cell-free molecular diagnostics, today announced the launch ... of the Company,s Precision Cancer Monitoring℠ (PCM) technology ... patients receiving one or a combination of the ... and Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient ...
Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
(Date:7/29/2015)... YORK , July 29, 2015  Therapath ... testing, announces increased partnerships with VA and Military ... Epidermal Nerve Fiber Density (ENFD) and Sweat Gland ... small fiber neuropathy ( https://therapath.com/skin ). ... Nerve Fiber Density (ENFD) on punch skin biopsy ...
(Date:7/29/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ) ... optimized Erk inhibitor molecule for development, thus achieving ... new class of potential cancer therapies. ... for therapeutic intervention in cancer. Recently approved compounds ... B-Raf and Mek inhibitors. Erk inhibitors may be ...
(Date:7/29/2015)... ... July 29, 2015 , ... Rainbow Scientific, Inc. (RSI), a ... availability of BI’s line of human mesenchymal stem cell (hMSC) differentiation media, ... offer a complete system for multipotency evaluation of hMSCs and reliable induction of ...
(Date:7/28/2015)... ... ... 530 sample changer for vials can be used with Anton Paar density meters, viscometers ... mPas (internal air) up to 36,000 (external air) – and can process up to 71 ... is its removable magazine, which is easily lifted off its hub and carried by hand ...
Breaking Biology Technology:Neuropathology services for VA and Military health systems 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 2Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 3New Moves in Automatic Sample Handling: Introducing Xsample 530 2
Cached News: